Lilopristone
N/A
Report date: 2022/08/23 20:00:44
NME
Base Information
Drug NameLilopristone
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[2]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer Schering Pharma Gmbh
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBayer Schering Pharma Gmbh
Active IndicationsN/A
Inactive Indications +[2]
Other Information
ATC CodeN/A
Related LinksN/A